Loading...
Docoh

Brendan Smith

Brendan Smith is Chief Financial Officer of CRISPR Therapeutics AG.

Person profile

Roles
CRISPR Therapeutics Chief Financial Officer
Translate Bio Chief Financial Officer
Address
Lexington, Massachusetts
Employees
SEC CIK

Calendar

25 Sep 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
16 Aug 22 CRSP CRISPR Therapeutics RSU Common Shares Grant Acquire A No No 0 10,000 0 10,000
18 Feb 22 CRSP CRISPR Therapeutics RSU Common Shares Grant Acquire A No No 0 15,300 0 15,300
18 Feb 22 CRSP CRISPR Therapeutics Stock Option Common Shares Grant Acquire A No No 58.29 30,000 1.75M 30,000
14 Oct 21 CRSP CRISPR Therapeutics Stock Option Common Shares Grant Acquire A No No 98.7 90,000 8.88M 90,000
14 Oct 21 CRSP CRISPR Therapeutics RSU Common Shares Grant Acquire A No No 0 15,000 0 15,000
14 Sep 21 TBIO Translate Bio Stcok Option Common Stock Sell Dispose S No No 19.23 201,800 3.88M 0
Financial reports
No filings
Current reports
No filings
Registration and prospectus
No filings
Proxies
No filings
Other
No filings